Back to search

Article

A drug candidate for treating adverse reactions caused by pathogenic antibodies inducible by COVID-19 virus and vaccines

2021-07-13

Abstract excerpt

<h4>Summary</h4> In a recent study, we reported that certain anti-spike antibodies of COVID-19 and SARS-CoV viruses can have a pathogenic effect through binding to sick lung epithelium cells and misleading immune responses to attack self-cells. We termed this new pathogenic mechanism “Antibody Dependent Auto-Attack” (ADAA). This study explores a drug candidate for prevention and treatment of such ADAA-based disea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4cab0d7b-f545-5ef2-9c08-c78c046a654d
DOI
10.1101/2021.07.13.452194
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A drug candidate for treating adverse reactions caused by pathogenic antibodies inducible by COVID-19 virus and vaccinesDOI 10.1101/2021.07.13.452194
Select a neighboring publication to make it the new centre.